Molecular genetics of primary and secondary hyperparathyroidism

被引：8

作者：

Dotzenrath, C ^{[1
]}

Goretzki, PE ^{[1
]}

Farnebo, F ^{[1
]}

Teh, BT ^{[1
]}

Weber, G ^{[1
]}

Roher, HD ^{[1
]}

Larsson, C ^{[1
]}

机构：

[1] KAROLINSKA HOSP, DEPT MOL MED, S-10401 STOCKHOLM, SWEDEN

来源：

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES | 1996年 / 104卷

关键词：

tumor-suppressor-genes; loss of heterozygosity; primary and secondary hyperparathyroidism; hereditary disease;

D O I：

10.1055/s-0029-1211714

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Hyperparathyroidism (HPT) can be caused by solitary parathyroid adenomas and carcinomas, and primary and secondary multiglandular parathyroid disease. Primary HPT is also a feature of several hereditary diseases e.g. multiple endocrine neoplasia type 1 and type 2A (MEN1 and 2A), familial hypocalciuric hyperparathyroidism (FHH), the HPT-jaw tumor syndrome (HPT-JT), and familial isolated HPT. Summarizing data from the literature and our own observations, various genetic abnormalities are observed in the pathogenesis of HPT. These include chromosomal deletions of the MEN1 locus on 11q in sporadic and MEN1 associated primary HPT, of RB1 on 13q in carcinomas, and of the FHH gene located on 3q in sporadic primary and secondary HPT. Genetic material is also lost from chromosomes 1p, 6q, 15q and X suggesting loss of yet unidentified tumor supressor genes in these regions. In addition the HRPT2 gene on 1q, as well as the proto-oncogenes RET on 10q and PRAD1 on 11q are associated with a subset of parathyroid tumors.

引用

页码：105 / 107

页数：3

共 13 条

[1] MONOCLONALITY OF PARATHYROID TUMORS IN CHRONIC-RENAL-FAILURE AND IN PRIMARY PARATHYROID HYPERPLASIA [J].

ARNOLD, A ;

BROWN, MF ;

URENA, P ;

GAZ, RD ;

SARFATI, E ;

DRUEKE, TB .

JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (05) :2047-2053

[2] LOSS OF THE RETINOBLASTOMA TUMOR-SUPPRESSOR GENE IN PARATHYROID CARCINOMA [J].

CRYNS, VL ;

THOR, A ;

XU, HJ ;

HU, SX ;

WIERMAN, ME ;

VICKERY, AL ;

BENEDICT, WF ;

ARNOLD, A .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (11) :757-761

[3] FREQUENT LOSS OF CHROMOSOME ARM IP DNA IN PARATHYROID ADENOMAS [J].

CRYNS, VL ;

YI, SM ;

TAHARA, H ;

GAZ, RD ;

ARNOLD, A .

GENES CHROMOSOMES & CANCER, 1995, 13 (01) :9-17

[4]

DOTZENRATH C, 1996, IN PRESS J CLIN ENDO

[5] PROGRESSION OF UREMIC HYPERPARATHYROIDISM INVOLVES ALLELIC LOSS ON CHROMOSOME-11 [J].

FALCHETTI, A ;

BALE, AE ;

AMOROSI, A ;

BORDI, C ;

CICCHI, P ;

BANDINI, S ;

MARX, SJ ;

BRANDI, ML .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (01) :139-144

[6]

FARNEBO F, UNPUB GENETIC STUDIE

[7] MULTIPLE ENDOCRINE NEOPLASIA TYPE-1 GENE MAPS TO CHROMOSOME-11 AND IS LOST IN INSULINOMA [J].

LARSSON, C ;

SKOGSEID, B ;

OBERG, K ;

NAKAMURA, Y ;

NORDENSKJOLD, M .

NATURE, 1988, 332 (6159) :85-87

[8] MUTATIONS IN THE HUMAN CA2+-SENSING RECEPTOR GENE CAUSE FAMILIAL HYPOCALCIURIC HYPERCALCEMIA AND NEONATAL SEVERE HYPERPARATHYROIDISM [J].

POLLAK, MR ;

BROWN, EM ;

CHOU, YHW ;

HEBERT, SC ;

MARX, SJ ;

STEINMANN, B ;

LEVI, T ;

SEIDMAN, CE ;

SEIDMAN, JG .

CELL, 1993, 75 (07) :1297-1303

[9]

ROSENBERG CL, 1991, ONCOGENE, V6, P449

[10]

SZABO J, 1995, AM J HUM GENET, V56, P944

← 1 2 →